John Groetelaars
Share |

 

John Groetelaars

Group President, CR Bard

John P. Groetelaars joined C. R. Bard, Inc. in 2008 as Vice President and General Manager, Davol Inc. in Warwick, RI. He was promoted to President of Davol in 2009.  In July 2013, he was promoted to Group Vice President, adding China, Asia and Australia/New Zealand to his current responsibilities for Davol. In July 2015, he was promoted to Group President and added Bard Access Systems to his current responsibilities for Davol, China, Australia / New Zealand and Rest of Asia.

Prior to Bard, he was most recently General Manager & Vice President for UK, Ireland and Nordic for Boston Scientific Corporation after previously serving as General Manager & Vice President for Canada. Prior to joining Boston Scientific in 2002, he held positions of increasing responsibility with Eli Lilly & Company and Guidant Corporation including Vice President, Cardiac Surgery Marketing and Business Development and Director and General Manager, Minimally Invasive Cardiac Surgery. John also held a number of sales, marketing and business development roles with Guidant. 

 John received a BS in Mechanical Engineering from Kettering University in Michigan and an MBA from Columbia University in New York.